Analyst Research: Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

19.57USD
21 Aug 2014
Price Change (% chg)

$-0.50 (-2.49%)
Prev Close
$20.07
Open
$20.07
Day's High
$20.18
Day's Low
$19.36
Volume
387,549
Avg. Vol
419,654
52-wk High
$22.30
52-wk Low
$9.71

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ALBANY MOLECULAR RESEARCH INCORPORATED (AMRI-O) 5:40am EDT Thomson Reuters Stock Report 12 25.00
AMRI: Due Diligence Review: Forensic Earnings and Valuation 20 Aug 2014 New Constructs, LLC 9 25.00
Wright Investors Service Comprehensive Report for Albany Molecular Research Incorporated 19 Aug 2014 Wright Reports 56 75.00
Albany Molecular Research, Inc.: Downgraded to Average 19 Aug 2014 Sadif Analytics (Premium) 3 10.00
"The Economy Matters" Report for AMRI: the economy's impact on AMRI's price and risk, featuring the powerful Economic Climate Rating 18 Aug 2014 MacroRisk Analytics/EconomicInvestor 7 25.00
ValuEngine Rating and Forecast Report for AMRI 17 Aug 2014 ValuEngine, Inc. 11 25.00
ALBANY MOL RSCH (AMRI) Zacks Company Snapshot 11 Aug 2014 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: ALBANY MOLECULAR RESH INC (AMRI) 9 Aug 2014 TheStreet.com Ratings 5 10.00
TheStreet.com Ratings Stock Report For: ALBANY MOLECULAR RESH INC (AMRI) 9 Aug 2014 TheStreet.com Ratings 5 10.00
AMRI.OQ - Event Transcript of Albany Molecular Research Inc conference call, Aug. 05, 2014 / 10:00AM ET 5 Aug 2014 Thomson Reuters StreetEvents 13 75.00
 
Name Age Since Current Position

Thomas D' Ambra

58 2013 Non-Executive Chairman of the Board

William Marth

59 2014 President, Chief Executive Officer, Director

Michael Nolan

49 2012 Chief Financial Officer, Vice President, Treasurer

George Svokos

56 2014 Senior Vice President - Sales, General Manager - API

Steven Hagen

53 2012 Senior Vice President - Manufacturing and Pharmaceuticals
Search Stocks